ROCKWELL MEDICAL, INC. Research and Development Expense
ROCKWELL MEDICAL, INC. (RMTI) reported Research and Development Expense of $40.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- ROCKWELL MEDICAL, INC. research and development expense for the quarter ending 2026-06-30 was $40.00K.
- ROCKWELL MEDICAL, INC. research and development expense for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- ROCKWELL MEDICAL, INC. research and development expense for the quarter ending 2025-09-30 was $0.00.
- ROCKWELL MEDICAL, INC. research and development expense for the quarter ending 2025-06-30 was $0.00.
- ROCKWELL MEDICAL, INC. research and development expense for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- ROCKWELL MEDICAL, INC. research and development expense for fiscal 2024 was $19.00K, a 98.28% decline from fiscal 2023.
- ROCKWELL MEDICAL, INC. research and development expense for fiscal 2023 was $1.11M.
- ROCKWELL MEDICAL, INC. research and development expense for fiscal 2018 was $5.64M, a 10.74% decline from fiscal 2017.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $40.00K 10-Q · filed 2026-08-13 | $40.00K 10-Q · filed 2026-08-13 | |||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 10-K · filed 2026-03-26 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $0.00 10-Q · filed 2025-11-12 | $1.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $1.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-12 | $1.00K derived: sum of 2 quarters · filed 2026-03-26 | $1.00K derived: sum of 3 quarters · filed 2026-03-26 | $1.00K derived: sum of 4 quarters · filed 2026-03-26 | |||
| 2024-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.00K derived: sum of 2 quarters · filed 2026-03-26 | $1.00K derived: sum of 3 quarters · filed 2026-03-26 | $19.00K 10-K · filed 2026-03-26 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $18.00K 10-Q · filed 2025-11-12 | $186.00K derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-14 | $18.00K 10-Q · filed 2025-08-14 | $186.00K derived: sum of 3 quarters · filed 2025-08-14 | $680.00K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $18.00K 10-Q · filed 2025-05-12 | $186.00K derived: sum of 2 quarters · filed 2025-05-12 | $680.00K derived: sum of 3 quarters · filed 2025-05-12 | $847.00K derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | $168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $662.00K derived: sum of 2 quarters · filed 2025-03-20 | $829.00K derived: sum of 3 quarters · filed 2025-03-20 | $1.11M 10-K · filed 2025-03-20 | |||
| 2023-09-30 | $494.00K 10-Q · filed 2024-11-12 | $661.00K derived: sum of 2 quarters · filed 2024-11-12 | $939.00K 10-Q · filed 2024-11-12 | ||||
| 2023-06-30 | $167.00K 10-Q · filed 2024-08-08 | $445.00K 10-Q · filed 2024-08-08 | |||||
| 2023-03-31 | $278.00K 10-Q · filed 2024-05-14 | ||||||
| 2022-09-30 | $469.00K 10-Q · filed 2023-11-14 | $1.40M derived: sum of 2 quarters · filed 2023-11-14 | $2.96M 10-Q · filed 2023-11-14 | ||||
| 2022-06-30 | $926.00K 10-Q · filed 2023-08-14 | $2.49M 10-Q · filed 2023-08-14 | |||||
| 2022-03-31 | $1.57M 10-Q · filed 2023-05-15 | ||||||
| 2021-09-30 | $1.22M 10-Q · filed 2022-11-14 | $3.64M derived: sum of 2 quarters · filed 2022-11-14 | $5.45M 10-Q · filed 2022-11-14 | ||||
| 2021-06-30 | $2.42M 10-Q · filed 2022-08-15 | $4.22M 10-Q · filed 2022-08-15 | |||||
| 2021-03-31 | $1.81M 10-Q · filed 2022-05-16 | ||||||
| 2020-09-30 | $1.75M 10-Q · filed 2021-11-15 | $3.36M derived: sum of 2 quarters · filed 2021-11-15 | $5.18M 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | $1.62M 10-Q · filed 2021-08-16 | $1.62M 10-Q · filed 2020-08-10 | $3.44M 10-Q · filed 2021-08-16 | $3.44M 10-Q · filed 2020-08-10 | |||
| 2020-03-31 | $1.82M 10-Q · filed 2021-05-17 | $1.82M 10-Q · filed 2020-05-11 | |||||
| 2019-09-30 | $1.48M 10-Q · filed 2020-11-09 | $1.47M 10-Q · filed 2019-11-12 | $4.43M derived: sum of 2 quarters · filed 2020-11-09 | $4.93M 10-Q · filed 2020-11-09 | $4.93M 10-Q · filed 2019-11-12 | $6.54M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $2.96M 10-Q · filed 2020-08-10 | $3.46M 10-Q · filed 2020-08-10 | $5.06M derived: sum of 3 quarters · filed 2020-08-10 | $5.87M derived: sum of 4 quarters · filed 2020-08-10 | |||
| 2019-03-31 | $497.28K 10-Q · filed 2020-05-11 | $2.11M derived: sum of 2 quarters · filed 2020-05-11 | $2.91M derived: sum of 3 quarters · filed 2020-05-11 | $4.47M derived: sum of 4 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $2.42M derived: sum of 2 quarters · filed 2019-11-12 | $3.98M derived: sum of 3 quarters · filed 2019-11-12 | $5.64M 10-K · filed 2019-03-18 | |||
| 2018-09-30 | $808.19K 10-Q · filed 2019-11-12 | $2.37M derived: sum of 2 quarters · filed 2019-11-12 | $4.03M 10-Q · filed 2019-11-12 | $6.16M derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | $1.56M 10-Q · filed 2019-08-09 | $3.23M 10-Q · filed 2019-08-09 | $5.35M derived: sum of 3 quarters · filed 2019-08-09 | $6.66M derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-03-31 | $1.67M 10-Q · filed 2019-05-10 | $3.79M derived: sum of 2 quarters · filed 2019-05-10 | $5.10M derived: sum of 3 quarters · filed 2019-05-10 | $6.77M derived: sum of 4 quarters · filed 2019-05-10 | |||
| 2017-12-31 | $2.13M 10-K · filed 2018-03-15 | $3.43M derived: sum of 2 quarters · filed 2018-11-09 | $5.11M derived: sum of 3 quarters · filed 2018-11-09 | $6.32M 10-K · filed 2019-03-18 | |||
| 2017-09-30 | $1.30M 10-Q · filed 2018-11-09 | $2.98M derived: sum of 2 quarters · filed 2018-11-09 | $4.20M 10-Q · filed 2018-11-09 | $5.40M derived: sum of 4 quarters · filed 2018-11-09 | |||
| 2017-06-30 | $1.68M 10-Q · filed 2018-08-14 | $2.89M 10-Q · filed 2018-08-14 | $4.09M derived: sum of 3 quarters · filed 2018-08-14 | $5.35M derived: sum of 4 quarters · filed 2018-08-14 | |||
| 2017-03-31 | $1.21M 10-Q/A · filed 2018-08-14 | $2.42M derived: sum of 2 quarters · filed 2018-08-14 | $3.68M derived: sum of 3 quarters · filed 2018-08-14 | $5.74M derived: sum of 4 quarters · filed 2018-08-14 | |||
| 2016-12-31 | $1.20M 10-K · filed 2018-03-15 | $2.46M derived: sum of 2 quarters · filed 2018-03-15 | $4.53M derived: sum of 3 quarters · filed 2018-03-15 | $5.84M 10-K · filed 2018-03-15 | |||
| 2016-09-30 | $1.26M 10-K · filed 2018-03-15 | $3.33M derived: sum of 2 quarters · filed 2018-03-15 | $4.64M 10-Q · filed 2017-11-08 | $6.67M derived: sum of 4 quarters · filed 2018-03-15 | |||
| 2016-06-30 | $2.06M 10-K · filed 2018-03-15 | $3.38M 10-Q · filed 2017-08-09 | $5.41M derived: sum of 3 quarters · filed 2018-03-15 | $6.65M derived: sum of 4 quarters · filed 2018-03-15 | |||
| 2016-03-31 | $1.31M 10-K · filed 2018-03-15 | $3.34M derived: sum of 2 quarters · filed 2018-03-15 | $4.59M derived: sum of 3 quarters · filed 2018-03-15 | $5.48M derived: sum of 4 quarters · filed 2018-03-15 | |||
| 2015-12-31 | $2.03M 10-K · filed 2017-03-15 | $3.28M derived: sum of 2 quarters · filed 2017-03-15 | $4.16M derived: sum of 3 quarters · filed 2017-03-15 | $4.96M 10-K · filed 2018-03-15 | |||
| 2015-09-30 | $1.25M 10-K · filed 2017-03-15 | $2.13M derived: sum of 2 quarters · filed 2017-03-15 | $2.93M 10-Q · filed 2016-11-07 | $4.61M derived: sum of 4 quarters · filed 2017-03-15 | |||
| 2015-06-30 | $885.26K 10-K · filed 2017-03-15 | $1.68M 10-Q · filed 2016-08-09 | $3.36M derived: sum of 3 quarters · filed 2017-03-15 | $4.67M derived: sum of 4 quarters · filed 2017-03-15 | |||
| 2015-03-31 | $799.59K 10-K · filed 2017-03-15 | $2.48M derived: sum of 2 quarters · filed 2017-03-15 | $3.78M derived: sum of 3 quarters · filed 2017-03-15 | $3.97M derived: sum of 4 quarters · filed 2017-03-15 | |||
| 2014-12-31 | $1.68M 10-K · filed 2016-02-29 | $2.98M derived: sum of 2 quarters · filed 2016-02-29 | $3.17M derived: sum of 3 quarters · filed 2016-02-29 | $7.78M 10-K · filed 2017-03-15 | |||
| 2014-09-30 | $1.30M 10-K · filed 2016-02-29 | $1.49M derived: sum of 2 quarters · filed 2016-02-29 | $6.10M 10-Q · filed 2015-11-09 | $11.90M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $186.69K 10-K · filed 2016-02-29 | $4.80M 10-Q · filed 2015-08-04 | $10.60M derived: sum of 3 quarters · filed 2016-02-29 | $21.21M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $4.62M 10-K · filed 2016-02-29 | $10.41M derived: sum of 2 quarters · filed 2016-02-29 | $21.02M derived: sum of 3 quarters · filed 2016-02-29 | $31.24M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $5.79M 10-K · filed 2015-03-03 | $16.40M derived: sum of 2 quarters · filed 2015-03-03 | $26.63M derived: sum of 3 quarters · filed 2015-03-03 | $39.38M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | $10.61M 10-K · filed 2015-03-03 | $20.83M derived: sum of 2 quarters · filed 2015-03-03 | $33.59M 10-Q · filed 2014-11-10 | $45.34M derived: sum of 4 quarters · filed 2015-03-03 | |||
| 2013-06-30 | $10.22M 10-K · filed 2015-03-03 | $22.98M 10-Q · filed 2014-07-31 | $34.73M derived: sum of 3 quarters · filed 2015-03-03 | $50.97M derived: sum of 4 quarters · filed 2015-03-03 | |||
| 2013-03-31 | $12.75M 10-K · filed 2015-03-03 | $24.51M derived: sum of 2 quarters · filed 2015-03-03 | $40.74M derived: sum of 3 quarters · filed 2015-03-03 | $51.62M derived: sum of 4 quarters · filed 2015-03-03 | |||
| 2012-12-31 | $11.75M 10-K · filed 2014-03-07 | $27.99M derived: sum of 2 quarters · filed 2014-03-07 | $38.87M derived: sum of 3 quarters · filed 2014-03-07 | $48.27M 10-K · filed 2015-03-03 | |||
| 2012-09-30 | $16.24M 10-K · filed 2014-03-07 | $27.11M derived: sum of 2 quarters · filed 2014-03-07 | $36.52M 10-Q · filed 2013-11-05 | $44.39M derived: sum of 4 quarters · filed 2014-03-07 | |||
| 2012-06-30 | $10.88M 10-K · filed 2014-03-07 | $20.28M 10-Q · filed 2013-08-01 | $28.15M derived: sum of 3 quarters · filed 2014-03-07 | $32.37M derived: sum of 4 quarters · filed 2014-03-07 | |||
| 2012-03-31 | $9.41M 10-K · filed 2014-03-07 | $17.27M derived: sum of 2 quarters · filed 2014-03-07 | $21.49M derived: sum of 3 quarters · filed 2014-03-07 | $24.81M derived: sum of 4 quarters · filed 2014-03-07 | |||
| 2011-12-31 | $7.87M 10-K · filed 2013-03-18 | $12.09M derived: sum of 2 quarters · filed 2013-03-18 | $15.40M derived: sum of 3 quarters · filed 2013-03-18 | $17.81M 10-K · filed 2014-03-07 | |||
| 2011-09-30 | $4.22M 10-K · filed 2013-03-18 | $7.53M derived: sum of 2 quarters · filed 2013-03-18 | $9.94M 10-Q · filed 2012-11-09 | $11.67M derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-06-30 | $3.31M 10-K · filed 2013-03-18 | $5.72M 10-Q · filed 2012-08-07 | $7.45M derived: sum of 3 quarters · filed 2013-03-18 | $8.18M derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-03-31 | $2.40M 10-K · filed 2013-03-18 | $4.14M derived: sum of 2 quarters · filed 2013-03-18 | $4.87M derived: sum of 3 quarters · filed 2013-03-18 | $5.31M derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2010-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $2.46M derived: sum of 2 quarters · filed 2013-03-18 | $2.90M derived: sum of 3 quarters · filed 2013-03-18 | $3.42M 10-K · filed 2013-03-18 | |||
| 2010-09-30 | $727.98K 10-Q · filed 2011-11-04 | $1.17M derived: sum of 2 quarters · filed 2011-11-04 | $1.69M 10-Q · filed 2011-11-04 | ||||
| 2010-06-30 | $441.27K 10-Q · filed 2011-08-05 | $958.69K 10-Q · filed 2011-08-05 | |||||
| 2009-12-31 | $6.45M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |